Patents Assigned to FEops NV
  • Publication number: 20250134643
    Abstract: The invention relates to determining a model of a cardiac implant deployed in a cardiac region of a patient. A database including a plurality of different records is provided, each record including at least data representative of an image of a cardiac region and an associated model of the cardiac implant deployed in said cardiac region. A patient-specific image of the cardiac region for which the model of the cardiac implant deployed in said cardiac region is to be determined, is received. An approximation of the patient-specific image of the cardiac region is calculated based on a weighted combination of images of the cardiac region in a plurality of records. The model of the cardiac implant deployed in the cardiac region associated to the patient-specific image of said cardiac region is determined based on weighted combination of models of the cardiac implant associated to the images of the cardiac region in the plurality of records used for approximating said patient-specific image of the cardiac region.
    Type: Application
    Filed: February 10, 2023
    Publication date: May 1, 2025
    Applicant: FEops NV
    Inventors: Nic DEBUSSCHERE, Vanda OLIVEIRA, Peter Eddy J. MORTIER
  • Publication number: 20250134597
    Abstract: A system and method for selecting, from a series of cardiac implants having different sizes, the cardiac implant having optimum size for implantation in a patient. The method includes obtaining data representative of a patient-specific cardiac region and predicting the optimum size of the cardiac implant best matching a predefined criterion when deployed in the cardiac region. The predicting includes querying a database; determining parameter values for a parametric model representation of the patient-specific cardiac region; and/or entering the data representative of the patient-specific cardiac region into an artificial intelligence device.
    Type: Application
    Filed: January 6, 2025
    Publication date: May 1, 2025
    Applicant: FEops NV
    Inventors: Matthieu Robert Anna Firmin DE BEULE, Peter Eddy J. MORTIER, Patricio Javier ASTUDILLO, Nic DEBUSSCHERE
  • Patent number: 12186021
    Abstract: A system and method for selecting, from a series of cardiac implants having different sizes, the cardiac implant having optimum size for implantation in a patient. The method includes obtaining data representative of a patient-specific cardiac region and predicting the optimum size of the cardiac implant best matching a predefined criterion when deployed in the cardiac region. The predicting includes querying a database; determining parameter values for a parametric model representation of the patient-specific cardiac region; and/or entering the data representative of the patient-specific cardiac region into an artificial intelligence device.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: January 7, 2025
    Assignee: FEops NV
    Inventors: Matthieu Robert Anna Firmin De Beule, Peter Eddy J. Mortier, Patricio Javier Astudillo, Nic Debusschere
  • Publication number: 20250006378
    Abstract: A system and method for evaluating a cardiac region of a subject from medical data. The method comprises obtaining, by the computer system, for a sequence of positions along a centerline of the coronary artery a sequence of associated luminal dimensions. The method comprises determining, by the computer system, data relating to a Fractional Flow Reserve, FFR, of the coronary artery by comparing the sequence of luminal dimensions of the coronary artery of the subject with one or more reference sequences of luminal dimensions. The method further comprises displaying the data relating to the FFR on a display.
    Type: Application
    Filed: June 28, 2023
    Publication date: January 2, 2025
    Applicant: FEops NV
    Inventors: Peter Eddy J. MORTIER, Maxime NAUWYNCK, Kilian MICHIELS, Eva HEFFINCK, Giorgia ROCATELLO
  • Publication number: 20230119535
    Abstract: Systems and methods for fully automated anatomical analysis of an anatomical structure are provided to facilitate pre-operative planning. The computerized method may include obtaining a plurality of images, e.g., MSCT images, of patient-specific cardiovascular anatomy, and analyzing the MSCT images with a trained artificial intelligence module to identify one or more anatomical landmarks and to construct a virtual three-dimensional model of the anatomical structure. For example, the trained artificial intelligence module may execute segmentation, point detection, curve detection, or plane detection deep learning modules, independently or in combination, to identify the anatomical landmarks. The method further may include deriving anatomical measurements of the one or more identified anatomical landmarks, and displaying the virtual three-dimensional model alongside the anatomical measurements of the one or more identified anatomical landmarks.
    Type: Application
    Filed: October 12, 2022
    Publication date: April 20, 2023
    Applicant: FEops NV
    Inventors: Kilian MICHIELS, Eva HEFFINCK, Patricio ASTUDILLO
  • Publication number: 20220273369
    Abstract: A method and system for predicting a measure of hemodynamic compromise as a result of transcatheter cardiac treatment. The method includes providing a patient-specific anatomical model representing cardiac region and an implant model representing a three-dimensional representation of a cardiac implant. The method includes virtually deploying said implant model into said patient-specific anatomical model. A deformation of the patient-specific anatomical model is calculated as a result of implant model deployment A measure of hemodynamic compromise is determined from the virtually deployed implant model and the deformed patient-specific anatomical model.
    Type: Application
    Filed: May 14, 2022
    Publication date: September 1, 2022
    Applicant: FEops NV
    Inventors: Peter Eddy J. MORTIER, Nic DEBUSSCHERE, Gianluca DE SANTIS, Tim DeZUTTER, Matthieu Robert Anna Firmin DE BEULE
  • Publication number: 20220172848
    Abstract: A method and system for patient-specific predicting of cyclic loading failure of a cardiac implant. The method includes providing an implant model representing a three dimensional mesh based representation of a cardiac implant, and providing a four-dimensional, 4D, patient-specific anatomical model representing a mesh based representation of a patient-specific cardiac region including a deployment site for the cardiac implant in a plurality of states corresponding to a plurality of moments in the cardiac cycle. A computer calculates deformation of the implant model deployed at the deployment site when, or before, the 4D patient-specific anatomical model transforms consecutively through the plurality of states, and the computer determines a risk of cyclic loading failure of the cardiac implant on the basis of the calculated implant deformation.
    Type: Application
    Filed: March 6, 2020
    Publication date: June 2, 2022
    Applicant: FEops NV
    Inventors: Sander DE BOCK, Gianluca DE SANTIS, Francesco IANNACCONE
  • Patent number: 11331149
    Abstract: A method and system for predicting a measure of hemodynamic compromise as a result of transcatheter cardiac treatment. The method includes providing a patient-specific anatomical model representing cardiac region and an implant model representing a three-dimensional representation of a cardiac implant. The method includes virtually deploying said implant model into said patient-specific anatomical model. A deformation of the patient-specific anatomical model is calculated as a result of implant model deployment A measure of hemodynamic compromise is determined from the virtually deployed implant model and the deformed patient-specific anatomical model.
    Type: Grant
    Filed: June 28, 2021
    Date of Patent: May 17, 2022
    Assignee: FEops NV
    Inventors: Peter Eddy J. Mortier, Nic Debusschere, Gianluca De Santis, Tim DeZutter, Matthieu Robert Anna Firmin De Beule
  • Publication number: 20210322103
    Abstract: A method and system for predicting a measure of hemodynamic compromise as a result of transcatheter cardiac treatment. The method includes providing a patient-specific anatomical model representing cardiac region and an implant model representing a three-dimensional representation of a cardiac implant. The method includes virtually deploying said implant model into said patient-specific anatomical model. A deformation of the patient-specific anatomical model is calculated as a result of implant model deployment A measure of hemodynamic compromise is determined from the virtually deployed implant model and the deformed patient-specific anatomical model.
    Type: Application
    Filed: June 28, 2021
    Publication date: October 21, 2021
    Applicant: FEops NV
    Inventors: Peter Eddy J. MORTIER, Nic DEBUSSCHERE, Gianluca DE SANTIS, Tim DeZUTTER, Matthieu Robert Anna Firmin DE BEULE
  • Patent number: 11141220
    Abstract: A method and system for determining a measure of a risk of a patient developing cardiac conduction abnormalities as a result of transcatheter cardiac treatment. The method includes providing a patient-specific anatomical model representing cardiac region and an implant model representing a finite element representation of a cardiac implant. The method includes virtually placing said implant model into said patient-specific anatomical model. A measure of mechanical interaction between the implant model and the patient-specific anatomical model is determined and a measure of risk of the patient developing cardiac conduction abnormalities is determined on the basis of the determined mechanical interaction.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: October 12, 2021
    Assignee: FEops NV
    Inventors: Peter Eddy J Mortier, Gianluca De Santis, Matthieu Robert Anna Firmin De Beule
  • Patent number: 11069136
    Abstract: In a first aspect, the present invention relates to a method for patient-specific virtual percutaneous implantation, comprising estimating a patient-specific anatomical model of a patient-specific aorta based on cardiovascular 2D or 3D medical image data and virtually deploying an implant model representing an implant into said patient-specific anatomical model. In a second aspect, the present invention provides a method for patient-specific virtual percutaneous implantation. In a third aspect, the present invention provides an implant for virtual percutaneous implantation. In a fourth aspect, the present invention provides a system for virtual percutaneous implantation.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: July 20, 2021
    Assignee: FEops NV
    Inventors: Peter Mortier, Gianluca De Santis
  • Patent number: 11051885
    Abstract: A method and system for predicting a measure of hemodynamic compromise as a result of transcatheter cardiac treatment. The method includes providing a patient-specific anatomical model representing cardiac region and an implant model representing a three-dimensional representation of a cardiac implant. The method includes virtually deploying said implant model into said patient-specific anatomical model. A deformation of the patient-specific anatomical model is calculated as a result of implant model deployment A measure of hemodynamic compromise is determined from the virtually deployed implant model and the deformed patient-specific anatomical model.
    Type: Grant
    Filed: August 26, 2020
    Date of Patent: July 6, 2021
    Assignee: FEops NV
    Inventors: Peter Eddy J. Mortier, Nic Debusschere, Gianluca De Santis, Tim DeZutter, Matthieu Robert Anna Firmin De Beule
  • Patent number: 11045256
    Abstract: A method and system for predicting a measure of hemodynamic compromise as a result of transcatheter cardiac treatment. The method includes providing a patient-specific anatomical model representing cardiac region and an implant model representing a three-dimensional representation of a cardiac implant. The method includes virtually deploying said implant model into said patient-specific anatomical model. A deformation of the patient-specific anatomical model is calculated as a result of implant model deployment A measure of hemodynamic compromise is determined from the virtually deployed implant model and the deformed patient-specific anatomical model.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: June 29, 2021
    Assignee: FEops NV
    Inventors: Peter Eddy J. Mortier, Nic Debusschere, Gianluca De Santis, Tim DeZutter, Matthieu Robert Anna Firmin De Beule
  • Publication number: 20210022806
    Abstract: A system and method for selecting, from a series of cardiac implants having different sizes, the cardiac implant having optimum size for implantation in a patient. The method includes obtaining data representative of a patient-specific cardiac region and predicting the optimum size of the cardiac implant best matching a predefined criterion when deployed in the cardiac region. The predicting includes querying a database; determining parameter values for a parametric model representation of the patient-specific cardiac region; and/or entering the data representative of the patient-specific cardiac region into an artificial intelligence device.
    Type: Application
    Filed: March 8, 2019
    Publication date: January 28, 2021
    Applicant: FEops NV
    Inventors: Matthieu Robert Anna Firmin DE BEULE, Peter Eddy J. MORTIER, Patricio Javier ASTUDILLO, Nic DEBUSSCHERE
  • Publication number: 20200390500
    Abstract: A method and system for predicting a measure of hemodynamic compromise as a result of transcatheter cardiac treatment. The method includes providing a patient-specific anatomical model representing cardiac region and an implant model representing a three-dimensional representation of a cardiac implant. The method includes virtually deploying said implant model into said patient-specific anatomical model. A deformation of the patient-specific anatomical model is calculated as a result of implant model deployment A measure of hemodynamic compromise is determined from the virtually deployed implant model and the deformed patient-specific anatomical model.
    Type: Application
    Filed: August 26, 2020
    Publication date: December 17, 2020
    Applicant: FEops NV
    Inventors: Peter Eddy J. MORTIER, Nic DEBUSSCHERE, Gianluca DE SANTIS, Tim DeZUTTER, Matthieu Robert Anna Firmin DE BEULE
  • Publication number: 20200364936
    Abstract: In a first aspect, the present invention relates to a method for patient-specific virtual percutaneous implantation, comprising estimating a patient-specific anatomical model of a patient-specific aorta based on cardiovascular 2D or 3D medical image data and virtually deploying an implant model representing an implant into said patient-specific anatomical model. In a second aspect, the present invention provides a method for patient-specific virtual percutaneous implantation. In a third aspect, the present invention provides an implant for virtual percutaneous implantation. In a fourth aspect, the present invention provides a system for virtual percutaneous implantation.
    Type: Application
    Filed: August 7, 2020
    Publication date: November 19, 2020
    Applicant: FEops NV
    Inventors: Peter MORTIER, Gianluca DE SANTIS
  • Patent number: 10789772
    Abstract: In a first aspect, the present invention relates to a method for patient-specific virtual percutaneous implantation, comprising estimating a patient-specific anatomical model of a patient-specific aorta based on cardiovascular 2D or 3D medical image data and virtually deploying an implant model representing an implant into said patient-specific anatomical model. In a second aspect, the present invention provides a method for patient-specific virtual percutaneous implantation. In a third aspect, the present invention provides an implant for virtual percutaneous implantation. In a fourth aspect, the present invention provides a system for virtual percutaneous implantation.
    Type: Grant
    Filed: April 23, 2013
    Date of Patent: September 29, 2020
    Assignee: FEops NV
    Inventors: Peter Mortier, Gianluca De Santis